Array Biopharma Inc (ARRY.OQ)

ARRY.OQ on NASDAQ Stock Exchange Global Market

7.75USD
10:32am EDT
Change (% chg)

$0.02 (+0.26%)
Prev Close
$7.73
Open
$7.78
Day's High
$7.78
Day's Low
$7.64
Volume
79,161
Avg. Vol
540,009
52-wk High
$8.59
52-wk Low
$2.98

ARRY.OQ

Chart for ARRY.OQ

About

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer. The Company’s wholly owned clinical stage drugs include Filanesib in Phase II clinical trials, is indicated for Kinesin spindle protein (KSP), inhibitor... (more)

Overall

Beta: 1.73
Market Cap(Mil.): $1,090.41
Shares Outstanding(Mil.): 141.06
Dividend: --
Yield (%): --

Financials

  ARRY.OQ Industry Sector
P/E (TTM): -- 312.37 38.84
EPS (TTM): -0.15 -- --
ROI: -4.85 -5.21 16.53
ROE: -45.75 -6.13 17.62
Search Stocks

BUZZ-Array BioPharma Inc: Eight-month high on Novartis deal

** Drug developer's shares rise as much as 24 pct to eight-month high of $4.84, the biggest intra-day jump in four-and-half years

04 Dec 2014

BUZZ-Array BioPharma Inc: Regains rights to cancer drug from Novartis

** Reaches agreement with Swiss drugmaker Novartis to regain rights to experimental cancer drug, binimetinib, currently being evaluated in three late-stage trials

03 Dec 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks